143 related articles for article (PubMed ID: 35847628)
21. A tissue cage model in calves for studies on pharmacokinetic/pharmacodynamic interactions of antimicrobials.
Greko C; Finn M; Ohagen P; Franklin A; Bengtsson B
Int J Antimicrob Agents; 2003 Oct; 22(4):429-38. PubMed ID: 14522106
[TBL] [Abstract][Full Text] [Related]
22. Biomechanical comparison of bioabsorbable cervical spine interbody fusion cages.
Pflugmacher R; Schleicher P; Gumnior S; Turan O; Scholz M; Eindorf T; Haas NP; Kandziora F
Spine (Phila Pa 1976); 2004 Aug; 29(16):1717-22. PubMed ID: 15303013
[TBL] [Abstract][Full Text] [Related]
23. [Experimental fusion of the sheep cervical spine. Part II: Effect of growth factors and carrier systems on interbody fusion].
Kandziora F; Scholz M; Pflugmacher R; Krummrey G; Schollmeier G; Schmidmaier G; Schnake KJ; Duda G; Raschke M; Haas NP
Chirurg; 2002 Oct; 73(10):1025-38. PubMed ID: 12395162
[TBL] [Abstract][Full Text] [Related]
24. IGF-I and TGF-beta1 application by a poly-(D,L-lactide)-coated cage promotes intervertebral bone matrix formation in the sheep cervical spine.
Kandziora F; Schmidmaier G; Schollmeier G; Bail H; Pflugmacher R; Görke T; Wagner M; Raschke M; Mittlmeier T; Haas NP
Spine (Phila Pa 1976); 2002 Aug; 27(16):1710-23. PubMed ID: 12195060
[TBL] [Abstract][Full Text] [Related]
25. Development of furnished cages for laying hens.
Appleby MC; Walker AW; Nicol CJ; Lindberg AC; Freire R; Hughes BO; Elson HA
Br Poult Sci; 2002 Sep; 43(4):489-500. PubMed ID: 12365505
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetic and pharmacodynamic modeling of anidulafungin (LY303366): reappraisal of its efficacy in neutropenic animal models of opportunistic mycoses using optimal plasma sampling.
Groll AH; Mickiene D; Petraitiene R; Petraitis V; Lyman CA; Bacher JS; Piscitelli SC; Walsh TJ
Antimicrob Agents Chemother; 2001 Oct; 45(10):2845-55. PubMed ID: 11557479
[TBL] [Abstract][Full Text] [Related]
27. A polycaprolactone-tricalcium phosphate composite scaffold as an autograft-free spinal fusion cage in a sheep model.
Li Y; Wu ZG; Li XK; Guo Z; Wu SH; Zhang YQ; Shi L; Teoh SH; Liu YC; Zhang ZY
Biomaterials; 2014 Jul; 35(22):5647-59. PubMed ID: 24743032
[TBL] [Abstract][Full Text] [Related]
28. Porous Shape-Persistent Organic Cage Compounds of Different Size, Geometry, and Function.
Mastalerz M
Acc Chem Res; 2018 Oct; 51(10):2411-2422. PubMed ID: 30203648
[TBL] [Abstract][Full Text] [Related]
29. Differential pharmacokinetics and pharmacokinetic/pharmacodynamic modelling of robenacoxib and ketoprofen in a feline model of inflammation.
Pelligand L; King JN; Hormazabal V; Toutain PL; Elliott J; Lees P
J Vet Pharmacol Ther; 2014 Aug; 37(4):354-66. PubMed ID: 24628410
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of carprofen in anaesthetized pigs: a preliminary study.
Bošnjak M; Kržan M; Tratar UL; Dolenc J; Čemažar M; Seliškar A
Vet Anaesth Analg; 2021 Jan; 48(1):35-41. PubMed ID: 33303396
[TBL] [Abstract][Full Text] [Related]
31. The Effect of Cervical Interbody Cage Morphology, Material Composition, and Substrate Density on Cage Subsidence.
Suh PB; Puttlitz C; Lewis C; Bal BS; McGilvray K
J Am Acad Orthop Surg; 2017 Feb; 25(2):160-168. PubMed ID: 28009709
[TBL] [Abstract][Full Text] [Related]
32. Influence of marbofloxacin on the pharmacokinetics and pharmacodynamics of tolfenamic acid in calves.
Sidhu PK; Landoni MF; Lees P
J Vet Pharmacol Ther; 2005 Feb; 28(1):109-19. PubMed ID: 15720523
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic and pharmacodynamic interactions of tolfenamic acid and marbofloxacin in goats.
Sidhu PK; Landoni MF; Lees P
Res Vet Sci; 2006 Feb; 80(1):79-90. PubMed ID: 16005916
[TBL] [Abstract][Full Text] [Related]
34. Bone morphogenetic protein-2 application by a poly(D,L-lactide)-coated interbody cage: in vivo results of a new carrier for growth factors.
Kandziora F; Bail H; Schmidmaier G; Schollmeier G; Scholz M; Knispel C; Hiller T; Pflugmacher R; Mittlmeier T; Raschke M; Haas NP
J Neurosurg; 2002 Jul; 97(1 Suppl):40-8. PubMed ID: 12120650
[TBL] [Abstract][Full Text] [Related]
35. In vivo antimicrobial activity of marbofloxacin against Pasteurella multocida in a tissue cage model in calves.
Cao C; Qu Y; Sun M; Qiu Z; Huang X; Huai B; Lu Y; Zeng Z
Front Microbiol; 2015; 6():759. PubMed ID: 26257726
[TBL] [Abstract][Full Text] [Related]
36. Evaluating the impact of predation by fish on the assemblage structure of fishes associated with seagrass (Heterozostera tasmanica) (Martens ex Ascherson) den Hartog, and unvegetated sand habitats.
Hindell JS; Jenkins GP; Keough MJ
J Exp Mar Biol Ecol; 2000 Dec; 255(2):153-174. PubMed ID: 11108849
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the effects of cage height and stocking density on the behaviour of laying hens in furnished cages.
Albentosa MJ; Cooper JJ; Luddem T; Redgate SE; Elson HA; Walker AW
Br Poult Sci; 2007 Feb; 48(1):1-11. PubMed ID: 17364534
[TBL] [Abstract][Full Text] [Related]
38. Solute diffusion through fibrotic tissue formed around protective cage system for implantable devices.
Prihandana GS; Ito H; Tanimura K; Yagi H; Hori Y; Soykan O; Sudo R; Miki N
J Biomed Mater Res B Appl Biomater; 2015 Aug; 103(6):1180-7. PubMed ID: 25303239
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic, pharmacodynamic and covariate analysis of subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma.
Moreau P; Karamanesht II; Domnikova N; Kyselyova MY; Vilchevska KV; Doronin VA; Schmidt A; Hulin C; Leleu X; Esseltine DL; Venkatakrishnan K; Skee D; Feng H; Girgis S; Cakana A; van de Velde H; Deraedt W; Facon T
Clin Pharmacokinet; 2012 Dec; 51(12):823-9. PubMed ID: 23018466
[TBL] [Abstract][Full Text] [Related]
40. Norfloxacin penetration into subcutaneous tissue cage fluid in rabbits and efficacy in vivo.
Rylander M; Norrby SR
Antimicrob Agents Chemother; 1983 Mar; 23(3):352-5. PubMed ID: 6221689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
